SG11202112246UA - Markers for identifying and quantifying of nucleic acid sequence mutation, expression, splice variant, translocation, copy number, or methylation changes - Google Patents
Markers for identifying and quantifying of nucleic acid sequence mutation, expression, splice variant, translocation, copy number, or methylation changesInfo
- Publication number
- SG11202112246UA SG11202112246UA SG11202112246UA SG11202112246UA SG11202112246UA SG 11202112246U A SG11202112246U A SG 11202112246UA SG 11202112246U A SG11202112246U A SG 11202112246UA SG 11202112246U A SG11202112246U A SG 11202112246UA SG 11202112246U A SG11202112246U A SG 11202112246UA
- Authority
- SG
- Singapore
- Prior art keywords
- polymerase chain
- chain reaction
- nucleic acid
- sequence
- oligonucleotide primer
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/6858—Allele-specific amplification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/154—Methylation markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/178—Oligonucleotides characterized by their use miRNA, siRNA or ncRNA
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Immunology (AREA)
- Analytical Chemistry (AREA)
- Genetics & Genomics (AREA)
- Physics & Mathematics (AREA)
- Pathology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oncology (AREA)
- Hospice & Palliative Care (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962843032P | 2019-05-03 | 2019-05-03 | |
| PCT/US2020/031044 WO2020227100A1 (en) | 2019-05-03 | 2020-05-01 | Markers for identifying and quantifying of nucleic acid sequence mutation, expression, splice variant, translocation, copy number, or methylation changes |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11202112246UA true SG11202112246UA (en) | 2021-12-30 |
Family
ID=73050598
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11202112246UA SG11202112246UA (en) | 2019-05-03 | 2020-05-01 | Markers for identifying and quantifying of nucleic acid sequence mutation, expression, splice variant, translocation, copy number, or methylation changes |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20220243263A1 (https=) |
| EP (1) | EP3963095A4 (https=) |
| JP (2) | JP2022530920A (https=) |
| CN (1) | CN115244188A (https=) |
| AU (1) | AU2020268885A1 (https=) |
| BR (1) | BR112021022084A2 (https=) |
| CA (1) | CA3135726A1 (https=) |
| IL (1) | IL287804A (https=) |
| SG (1) | SG11202112246UA (https=) |
| WO (1) | WO2020227100A1 (https=) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3127329A1 (en) | 2019-01-24 | 2020-07-30 | Mayo Foundation For Medical Education And Research | Detecting endometrial cancer |
| US11702704B2 (en) | 2019-10-31 | 2023-07-18 | Mayo Foundation For Medical Education And Research | Detecting ovarian cancer |
| EP4267763B1 (en) * | 2020-12-24 | 2025-07-23 | Life Technologies Corporation | Compositions and methods for highly sensitive detection of target sequences in multiplex reactions |
| CA3211005A1 (en) * | 2021-03-05 | 2022-09-09 | Mayo Foundation For Medical Education And Research | Detecting cervical cancer |
| WO2022246000A1 (en) * | 2021-05-19 | 2022-11-24 | City Of Hope | Compositions and methods for determining dna methylation level in cancer |
| WO2023017001A1 (en) * | 2021-08-09 | 2023-02-16 | Epigenomics Ag | Improved methods for detecting colorectal cancer |
| CA3268032A1 (en) * | 2022-09-23 | 2024-03-28 | Flagship Pioneering Innovations Vi, Llc | NUCLEIC ACID AMPLIFICATION PROCESSES |
| WO2024154075A1 (en) * | 2023-01-18 | 2024-07-25 | Pixelgen Technologies Ab | Gap-fill ligation and primer extension reactions employing exonuclease-resistant or capture moiety means |
| AU2024263920A1 (en) * | 2023-04-24 | 2025-11-13 | Saga Diagnostics Ab | Detection of variants |
| WO2024259135A1 (en) | 2023-06-13 | 2024-12-19 | Intellia Therapeutics, Inc. | Assays for analysis of ribonucleic acid (rna) molecules |
| CN117305312B (zh) * | 2023-10-19 | 2024-08-20 | 西南大学 | 一个家蚕专一取食桑叶的决定基因Zfh3及其应用 |
| US20250223652A1 (en) * | 2024-01-05 | 2025-07-10 | Harbinger Health, Inc. | Tiered testing for high risk populations |
| CN118986863A (zh) * | 2024-10-18 | 2024-11-22 | 四川新泌学生物科技有限公司 | 一种外阴用外泌体凝胶及其制备方法 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE342378T1 (de) * | 1999-03-19 | 2006-11-15 | Cornell Res Foundation Inc | Verfahren das auf den gekoppelten reactionen der polymerase-kettenreaktion (pcr)-verdauung mit restriktionsenzymen und ligasenachweis basiert |
| EP2386654A1 (en) * | 2005-05-02 | 2011-11-16 | University of Southern California | DNA Methylation markers associated with the CpG island methylator phenotype (cimp) in human colorectal cancer |
| EP2129796B1 (en) * | 2007-02-21 | 2013-10-23 | Oslo Universitetssykehus HF | New markers for cancer |
| SG11201404899VA (en) * | 2012-02-14 | 2014-10-30 | Univ Cornell | Method for relative quantification of nucleic acid sequence, expression, or copy changes, using combined nuclease, ligation, and polymerase reactions |
| SI4056712T1 (sl) * | 2012-09-20 | 2024-10-30 | The Chinese University Of Hong Kong | Neinvazivno določanje metiloma tumorja iz plazme |
| US10155991B2 (en) * | 2013-08-15 | 2018-12-18 | Xueliang James Xia | Biomarkers for use in colorectal cancer |
| PT3204520T (pt) * | 2014-10-08 | 2020-04-16 | Univ Cornell | Método de identificação e quantificação da expressão de ácidos nucleicos, variantes de splicing, translocação, número de cópias ou alterações de metilação |
| US10030272B2 (en) * | 2015-02-27 | 2018-07-24 | Mayo Foundation For Medical Education And Research | Detecting gastrointestinal neoplasms |
| US10829804B2 (en) * | 2015-03-23 | 2020-11-10 | The University Of North Carolina At Chapel Hill | Method for identification and enumeration of nucleic acid sequences, expression, splice variant, translocation, copy, or DNA methylation changes using combined nuclease, ligase, polymerase, terminal transferase, and sequencing reactions |
| ES2835866T5 (es) * | 2015-05-12 | 2024-12-02 | Hoffmann La Roche | Procedimientos terapéuticos y de diagnóstico para el cáncer |
| GB201511152D0 (en) * | 2015-06-24 | 2015-08-05 | Ucl Business Plc | Method of diagnosing bladder cancer |
| WO2018087129A1 (en) * | 2016-11-08 | 2018-05-17 | Region Nordjylland, Aalborg University Hospital | Colorectal cancer methylation markers |
| CA3076386A1 (en) * | 2017-09-29 | 2019-04-04 | Arizona Board Of Regents On Behalf Of The University Of Arizona | Dna methylation biomarkers for cancer diagnosing |
-
2020
- 2020-05-01 JP JP2021565022A patent/JP2022530920A/ja active Pending
- 2020-05-01 WO PCT/US2020/031044 patent/WO2020227100A1/en not_active Ceased
- 2020-05-01 SG SG11202112246UA patent/SG11202112246UA/en unknown
- 2020-05-01 CN CN202080048135.9A patent/CN115244188A/zh active Pending
- 2020-05-01 US US17/608,537 patent/US20220243263A1/en active Pending
- 2020-05-01 AU AU2020268885A patent/AU2020268885A1/en active Pending
- 2020-05-01 BR BR112021022084A patent/BR112021022084A2/pt unknown
- 2020-05-01 CA CA3135726A patent/CA3135726A1/en active Pending
- 2020-05-01 EP EP20801778.0A patent/EP3963095A4/en active Pending
-
2021
- 2021-11-02 IL IL287804A patent/IL287804A/en unknown
-
2025
- 2025-06-02 JP JP2025091539A patent/JP2026002789A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| IL287804A (en) | 2022-01-01 |
| EP3963095A4 (en) | 2023-01-25 |
| WO2020227100A1 (en) | 2020-11-12 |
| WO2020227100A8 (en) | 2022-01-13 |
| BR112021022084A2 (pt) | 2022-02-08 |
| EP3963095A1 (en) | 2022-03-09 |
| AU2020268885A1 (en) | 2021-12-02 |
| CA3135726A1 (en) | 2020-11-12 |
| JP2026002789A (ja) | 2026-01-08 |
| CN115244188A (zh) | 2022-10-25 |
| US20220243263A1 (en) | 2022-08-04 |
| JP2022530920A (ja) | 2022-07-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG11202112246UA (en) | Markers for identifying and quantifying of nucleic acid sequence mutation, expression, splice variant, translocation, copy number, or methylation changes | |
| AU2022202083C1 (en) | Detecting mutations and ploidy in chromosomal segments | |
| Kazachenka et al. | Identification, characterization, and heritability of murine metastable epialleles: implications for non-genetic inheritance | |
| Tai et al. | Engineering microdeletions and microduplications by targeting segmental duplications with CRISPR | |
| Chen et al. | The reverse evolution from multicellularity to unicellularity during carcinogenesis | |
| Konkel et al. | Sequence analysis and characterization of active human Alu subfamilies based on the 1000 genomes pilot project | |
| KR20220012849A (ko) | 단일 세포 유전 구조 변이의 포괄적인 검출 | |
| CN109415763A (zh) | 捕获无细胞的甲基化dna的方法及其用途 | |
| US20220205050A1 (en) | Method and markers for identifying and quantifying of nucleic acid sequence, mutation, copy number, or methylation changes | |
| US20230287484A1 (en) | Method and markers for identification and relative quantification of nucleic acid sequence, mutation, copy number, or methylation changes using combinations of nuclease, ligation, deamination, dna repair, and polymerase reactions with carryover prevention | |
| Postel et al. | Transcriptome analysis provides critical answers to the “variants of uncertain significance” conundrum | |
| Hawley et al. | Reorganization of the 3D genome pinpoints noncoding drivers of primary prostate tumors | |
| Florez-Vargas et al. | Genetic regulation of TERT splicing affects cancer risk by altering cellular longevity and replicative potential | |
| Jalan et al. | RNA transcripts serve as a template for double-strand break repair in human cells | |
| CN113227393A (zh) | 用于校准表观遗传分区测定的方法、组合物和系统 | |
| Wendte et al. | The Pol IV largest subunit CTD quantitatively affects siRNA levels guiding RNA-directed DNA methylation | |
| Flegel et al. | Frameshift variations in the RHD coding sequence: Molecular mechanisms permitting protein expression | |
| US11718873B2 (en) | Correcting for deamination-induced sequence errors | |
| CN112301432B (zh) | 一种构建全基因组高通量测序的文库的方法和试剂盒 | |
| Chen et al. | scCircle-seq unveils the diversity and complexity of circular DNAs in single cells | |
| Díaz Navarro | Development of a tool for the identification of somatic mutations and analysis of non-coding mutations in cancer | |
| Florez-Vargas et al. | Genetic regulation of TERT splicing contributes to reduced or elevated cancer risk by altering cellular longevity and replicative potential | |
| Jarvis | Delineating the APOBEC3 Enzymes Responsible for the APOBEC Mutation Signature in Cancer | |
| Pančíková et al. | Long-read single-cell genome, transcriptome and open chromatin profiling links genotype to phenotypes | |
| Weaver | Driver genes, mutational signatures and the timing of mutations in oesophageal adenocarcinoma |